ArticleMedComm2022

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant.

Zhongcheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.